SCHEMBL7334597

SCHEMBL7334597

CN(C)c1ccc(-c2cccc(C(=O)N3CCN(C(c4ccccc4)c4ccccc4)CC3)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.61
ABL1 P00519 3/20 0.51
BCR P11274 3/20 0.51
USP2 O75604 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
SLC6A7 Q99884 1/20 0.49
KMT2A Q03164 5/20 0.49
ALDH1A1 P00352 3/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7336017 0.87 MAOB (0.65) MAOBUSP2CYP3A4CYP1A2CYP2D6
SCHEMBL7329517 0.84 MEN1 (0.65) MAOBUSP2CYP3A4CYP1A2CYP2D6
SCHEMBL4754213 0.78 MAOB (0.74) MAOBUSP2CYP3A4CYP1A2CYP2D6
SCHEMBL31350855 0.78 MAOB (0.61) MAOBUSP2TSHRKMT2AALDH1A1
SCHEMBL19464784 0.78 SLC6A7 (0.60) MAOBUSP2TSHRSLC6A7KMT2A
SCHEMBL31350986 0.78 MAOB (1.00) MAOBUSP2CYP1A2CYP2D6CYP2C9
SCHEMBL27405138 0.77 MAOB (0.60) MAOBUSP2CYP1A2CYP2D6CYP2C9
SCHEMBL31350890 0.76 USP2 (0.80) MAOBUSP2CYP3A4CYP1A2CYP2D6
SCHEMBL16598693 0.76 MAOB (0.74) MAOBUSP2CYP3A4CYP1A2CYP2D6
SCHEMBL4753326 0.76 USP2 (0.80) MAOBUSP2CYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 WO disclosed